Preventive effects of ellagic acid against doxorubicin-induced cardio-toxicity in mice - PubMed (original) (raw)
Preventive effects of ellagic acid against doxorubicin-induced cardio-toxicity in mice
Ming-Cheng Lin et al. Cardiovasc Toxicol. 2013 Sep.
Abstract
Preventive effects of ellagic acid against doxorubicin-induced cardiac oxidative, inflammatory and apoptotic stress were examined. This agent at 0.25, 0.5 or 1% was added in feed and supplied to mice for 8 weeks, and followed by doxorubicin treatment. Ellagic acid intake increased its deposit in heart. Pre-intake of this compound at 0.5 and 1% significantly attenuated doxorubicin caused increase in plasma creatine phosphokinase activity. Doxorubicin treatment decreased glutathione content, increased reactive oxygen species (ROS), malonyldialdehyde (MDA), interleukin (IL)-6, IL-10, monocyte chemoattractant protein-1 and tumor necrosis factor-alpha levels, declined glutathione peroxidase (GPX) and superoxide dismutase (SOD) activities, and enhanced xanthine oxidases (XO) activity in heart. Ellagic acid intake dose-dependently reserved glutathione content, lowered ROS and MDA levels, and reduced XO activity. This compound at 0.5 and 1% retained GPX and SOD activities, and decreased cytokines in heart. Doxorubicin treatment raised cardiac activity and protein production of caspase-3, nuclear factor kappa B (NF-κB) p50 and p65. Ellagic acid dose-dependently lowered caspase-3 activity and cleaved caspase-3 formation, and at 0.5 and 1% declined activity and protein level of NF-κB. Doxorubicin treatment also up-regulated cardiac expression of p-p38, p-ERK 1/2 and p-JNK, and ellagic acid at 0.5 and 1% suppressed p-p38 expression and at 1% down-regulated p-ERK 1/2 expression. These findings suggest that ellagic acid is a potent cardiac protective agent against doxorubicin.
Similar articles
- Dietary trans fats enhance doxorubicin-induced cardiotoxicity in mice.
Mong MC, Hsia TC, Yin MC. Mong MC, et al. J Food Sci. 2013 Oct;78(10):H1621-H1628. doi: 10.1111/1750-3841.12257. Epub 2013 Sep 11. J Food Sci. 2013. PMID: 24024564 - Doxorubicin mediated cardiotoxicity in rats: protective role of felodipine on cardiac indices.
Gandhi H, Patel VB, Mistry N, Patni N, Nandania J, Balaraman R. Gandhi H, et al. Environ Toxicol Pharmacol. 2013 Nov;36(3):787-95. doi: 10.1016/j.etap.2013.07.007. Epub 2013 Jul 22. Environ Toxicol Pharmacol. 2013. PMID: 23958971 - Salvianolic acids prevent acute doxorubicin cardiotoxicity in mice through suppression of oxidative stress.
Jiang B, Zhang L, Li M, Wu W, Yang M, Wang J, Guo DA. Jiang B, et al. Food Chem Toxicol. 2008 May;46(5):1510-5. doi: 10.1016/j.fct.2007.12.020. Epub 2008 Jan 30. Food Chem Toxicol. 2008. PMID: 18234414 - Differential inhibitory effects of the polyphenol ellagic acid on inflammatory mediators NF-kappaB, iNOS, COX-2, TNF-alpha, and IL-6 in 1,2-dimethylhydrazine-induced rat colon carcinogenesis.
Umesalma S, Sudhandiran G. Umesalma S, et al. Basic Clin Pharmacol Toxicol. 2010 Aug;107(2):650-5. doi: 10.1111/j.1742-7843.2010.00565.x. Epub 2010 Apr 14. Basic Clin Pharmacol Toxicol. 2010. PMID: 20406206 - A Pharmacological Update of Ellagic Acid.
Ríos JL, Giner RM, Marín M, Recio MC. Ríos JL, et al. Planta Med. 2018 Oct;84(15):1068-1093. doi: 10.1055/a-0633-9492. Epub 2018 May 30. Planta Med. 2018. PMID: 29847844 Review.
Cited by
- Prophylactic impacts of Lagenaria siceraria against cardiomyopathy induced by doxorubicin in a rat model.
Almohmadi NH, Zahran M, El-Nabtity SM, Shaheen HM. Almohmadi NH, et al. Open Vet J. 2024 Jul;14(7):1668-1676. doi: 10.5455/OVJ.2024.v14.i7.16. Epub 2024 Jul 31. Open Vet J. 2024. PMID: 39175975 Free PMC article. - An overview on the protective effects of ellagic acid against heavy metals, drugs, and chemicals.
Jamshidi Z, Roohbakhsh A, Karimi G. Jamshidi Z, et al. Food Sci Nutr. 2023 Sep 26;11(12):7469-7484. doi: 10.1002/fsn3.3704. eCollection 2023 Dec. Food Sci Nutr. 2023. PMID: 38107104 Free PMC article. Review. - Overexpressed SIRT6 ameliorates doxorubicin-induced cardiotoxicity and potentiates the therapeutic efficacy through metabolic remodeling.
Peng K, Zeng C, Gao Y, Liu B, Li L, Xu K, Yin Y, Qiu Y, Zhang M, Ma F, Wang Z. Peng K, et al. Acta Pharm Sin B. 2023 Jun;13(6):2680-2700. doi: 10.1016/j.apsb.2023.03.019. Epub 2023 Mar 25. Acta Pharm Sin B. 2023. PMID: 37425037 Free PMC article. - Punica granatum L. Extract Shows Cardioprotective Effects Measured by Oxidative Stress Markers and Biomarkers of Heart Failure in an Animal Model of Metabolic Syndrome.
Niewiadomska J, Kasztura M, Janus I, Chełmecka E, Stygar DM, Frydrychowski P, Wojdyło A, Noszczyk-Nowak A. Niewiadomska J, et al. Antioxidants (Basel). 2023 May 25;12(6):1152. doi: 10.3390/antiox12061152. Antioxidants (Basel). 2023. PMID: 37371882 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous